Dupilumab effectiveness in patients with type 2-high severe asthma and chronic rhinosinusitis with nasal polyps
S. Nolasco (Catania, Italy), R. Campisi (Catania, Italy), A. Cipolla (Catania, Italy), P. Impellizzeri (Catania, Italy), M. Bonsignore (Catania, Italy), N. Crimi (Catania, Italy), C. Crimi (Catania, Italy)
Source: International Congress 2022 – Translational studies of asthma and COPD
Session: Translational studies of asthma and COPD
Session type: Thematic Poster
Number: 4324
 
Rating: 
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
S. Nolasco (Catania, Italy), R. Campisi (Catania, Italy), A. Cipolla (Catania, Italy), P. Impellizzeri (Catania, Italy), M. Bonsignore (Catania, Italy), N. Crimi (Catania, Italy), C. Crimi (Catania, Italy). Dupilumab effectiveness in patients with type 2-high severe asthma and chronic rhinosinusitis with nasal polyps. 4324
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
|
|